HMPQ Sees Big Revenue from Online CBD Sales=====================
HempAmericana, Inc (HMPQ)
Alert Price: $0.0052
Chart Analysis
Website | Recent News
E-commerce:
www.hempamericana.com
========================
Members,
We've just identified another incredible opportunity in the CBD sector.
Please turn your immediate attention to HempAmericana, Inc (HMPQ).
Just like Tuesday's big winner, HMPQ is sitting on a bottom'd out chart, and appears to have nowhere to go but up from here.
The timing of this alert couldn't have been any better.
Cannabis stocks are set to rally across the board, as investors return to the beaten-down-sector with a fresh enthusiasm, following a historic House vote in favor of a bill that would lift the federal ban on weed.
The vote may have also triggered Bank of America's upgrade of Canopy Growth.
Bank of America analyst Christopher Carey upgraded Canopy Growth's stock to a buy rating from a neutral rating.
This upgrade appears to have had a halo effect on the entire CBD sector!
In our opinion, HMPQ is your best bet to capitalize on this CBD rally.
The Company dropped huge news today that may have not yet grabbed the full attention of the Street.
HMPQ has started to substantially increase its rate of production of CBD-based products in response to stronger than anticipated ecommerce demand following the full launch of its online sales portal.
The Company reported that due to this strong market response, HempAmericana will be upgrading its ecommerce platform to further amplify its digital presence and drive further growth in sales.
“We have seen a massive market response as we ramp up our initial ecommerce distribution activity,” commented Salvadore Rosillo, CEO of HempAmericana. “It’s working. And our number one concern is delivering shareholder value, which means we are ready and willing to facilitate further expansion through this channel.”
It looks like some serious revenue growth is on the horizon for HMPQ.
In addition to today's blockbuster announcement, we see several bullish catalysts on the horizon for HMPQ.
Yesterday the Company signed a Letter of Intent (LOI) with Smart Decision, Inc. (“SDEC”), an emerging leader in the CBD products market, to market and recommend HempAmericana products on the Company’s algorithmic affiliate marketing platform.
When you take into account the upcoming bullish catalysts, and all of the milestones the Company has reached this year, we think you'll agree that it is currently undervalued and oversold at the current share price.
Salvador Rosillo, CEO of HempAmericana, stated, "We're excited to have the opportunity to work with Smart Decision. Our operations and CBD manufacturing processes are a natural fit for Smart Decision’s unique marketing Platform. in the CBD space. CBDSmartDecision.com will be the first company that has HempAmericana’s permission to recommend and market their product on the affiliate level. This strategic move for our company puts us on the right path of success for our shareholders”
We believe this to be an exciting time for HMPQ and their shareholders.
With so much upside potential from today's alert price, we are urging all of our members to immediately start their research on HMPQ, and to add it to the top of their watchlist immediately.
About HempAmericana, Inc.
HempAmericana is an emerging leader in the CBD products market. The Company owns and operates a high-capacity, state-of-the-art CBD extraction and processing facility located in Augusta, Maine. This facility is armed with a supersized supercritical CO2 extraction system, centrifugal partition chromatography refinement technology, and a mechanized fully-automated CBD bottling system. The Company’s CBD oil business uses the brand designation, “Weed Got Oil”. HempAmericana also researches, develops, and sells products made of industrial hemp, including a popular brand of hemp rolling papers marketed under the brand name, “Rolling Thunders”. See more at www.hempamericana.com.
HMPQ Brings In Serious Revenue With The Launch Of Their eCommerce Portal
Earlier this month, HMPQ announced the initiation of live ecommerce sales of premium CBD-based products through the Company’s new online sales portal (hempamericana.com). The Company has already received a growing number of orders for full-spectrum CBD oil , with sales of 125mg thru 2000mg 1oz bottles already booked and in transit.
“The initial market response has been extremely gratifying to see,” commented Salvadore Rosillo, CEO of HempAmericana. “Following the official launch of our new online CBD sales portal, traffic has been strong and we anticipate robust sales growth ahead.”
The Company accelerated its timeframe to launch the online sales portal in response to research demonstrating a further jump in the growth rate for the overall CBD-based products market during the back half of 2019. According to research from MRFR, the global CBD market, which was valued at just over 3.08 billion in 2018, is estimated to register a CAGR of 125.58% from 2019 to 2026. The Brightfield Group joins in this appraisal, noting that 2019 alone is expected to show growth of over 900%.
Management believes that this rampant growth is due to widespread mainstream consumer adoption of CBD and CBD-based products. This mainstream adoption trend has accelerated as CBD products have become increasingly common on the shelves of major brand name physical retail stores. This increased awareness is feeding back into online search and ecommerce portal opportunities, creating a growing opportunity for HempAmericana and its shareholders.
Mr. Rosillo continued, “The market for CBD-based products continues to thrive, with growth accelerating aggressively so far in 2019, especially during the second half of the year. It’s the perfect time to be fully engaged as a major player in this market space. And we have a number of strategies set to roll out that will increase our share of the boom.”
Management also notes that the Company is currently in discussions with several potential distributors who are interested in helping HempAmericana sell its products on a much larger scale. More details will follow shortly.
Recent Developments
HempAmericana Announces Significant Increase in CBD Production Following Rapid Inventory Drawdown Through Online Sales Activity
HMPQ has begun to substantially increase its rate of production of CBD-based products in response to stronger than anticipated ecommerce demand following the full launch of its online sales portal.
The Company is also excited to report that, due to this strong market response, HempAmericana will be upgrading its ecommerce platform to further amplify its digital presence and drive further growth in sales.
“We have seen a massive market response as we ramp up our initial ecommerce distribution activity,” commented Salvadore Rosillo, CEO of HempAmericana. “It’s working. And our number one concern is delivering shareholder value, which means we are ready and willing to facilitate further expansion through this channel.”
The Company is also very pleased to see powerful steps being taken by lawmakers now pushing for US legalization of cannabis. The House Judiciary Committee approved a Bill on Wednesday that would decriminalize marijuana at the federal level. The Marijuana Opportunity Reinvestment and Expungement Act of 2019 (the “MORE Act”) passed by a wide margin, 24-10, with bipartisan support.
The Company applauds this step, which holds the potential to level the playing field for the cannabis and hemp-related products marketplace, laying a foundation whereby companies in these industries will be treated as law-abiding citizens , gaining access to the infrastructural resources that other industries take for granted, such as the banking system.
Mr. Rosillo continued, “After everything we’ve invested in this process, it’s tremendous to see the wheels in motion and product going out the door. The fact that it’s going out the door faster than we anticipated is a great problem to have. And we know exactly how to deal with it. It’s also terrific to see the gradual and seemingly inexorable process of full cannabis legalization in the US speed up a notch. We’re very excited about the opportunities that lie ahead.”
Market Outlook
Brightfield Group, a leading market and consumer intelligence firm for the legal CBD and cannabis industries, reported significant expected acceleration in growth for the CBD market, resulting in a 706% year-over-year CBD product sales jump in the US in 2019 to around $5 billion in total sales, with sales expected to reach $23.7 billion by 2023. This suggests the overall CBD-based products market is set to grow by a stunning 107% CAGR over coming years.
According to the Marijuana Business Factbook, retail sales of medical and recreational cannabis in the United States are on pace to eclipse $12 billion by the end of this year. This would be an increase of roughly 35% over 2018.
Retail sales could rise as high as $30 billion by 2023!
It was a banner year in 2018 with investors pouring an amazing $10 billion into cannabis in North America.
There has been a tremendous amount of positive buzz surrounding the legal marijuana industry, especially with politician on board to decriminalize the plant. This has helped marijuana stocks witness supreme rallies in recent years.
When the Food and Drug Administration approves the first pharmaceutical drug made from cannabis, it says something. When Corona Beer’s owner makes a $4 billion bet on a marijuana firm called Canopy Growth it says something.
When one marijuana company called Tilray Inc . sees its shares explode from under $60 to over $200 in just three weeks after making its debut in the market, it says something.
When one analyst predicts that legal marijuana could soon become a bigger industry than soda, it says something.
One of the top marijuana analysts, Vivien Azer at Cowen, is also calling for total U.S. cannabis sales to hit $80 billion by 2030!
A survey from Yahoo News and Marist College, has additionally illustrated just how mainstream marijuana has become. Nearly 55 million adults currently use the drug. Let’s face it, we are in a MARIJUANA REVOLUTION!
Over the years, research has yielded results that indicate marijuana may be beneficial in the treatment of many conditions including chronic pain, drug addiction, anxiety, PTSD, neurological disorders, and cancer.
This dynamic has helped raise awareness of the health benefits now being attributed to CBD , which has become known for its ability to help treat minor issues such as headaches and inflammation as well as contributing in care for more serious ailments, such as cancer, epilepsy, and multiple sclerosis. the growth rate for the overall CBD-based products market has been accelerating during the second half of 2019. According to research from MRFR, the global CBD market is estimated to register a stunning CAGR of 125% from 2019 to 2026.
Technical Analysis
We've done our very own chart analysis, and see the potential for a move of around +46%!
Key Indicators
Strong Base Built with Multiple Bounces Off Support
Bullish Trajectory and Cross
Buy Signal on MACD Cross Above Zero Line
Bullish Uptrend Divergence Against Price Action
Momentum is a Leading Indicator and is Signaling a Rise is imminent
The Bottom Line
Cannabis stocks are set to rally across the board, as investors return to the beaten-down-sector with a fresh enthusiasm, following a historic House vote in favor of a bill that would lift the federal ban on weed.
In our opinion, HMPQ is your best bet to capitalize on this CBD rally.
We believe this to be an exciting time for HMPQ and their shareholders.
With so much upside potential from today's alert price, we are urging all of our members to immediately start their research on HMPQ, and to add it to the top of their watchlist immediately.
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
Best Regards,
Past performance is not an indicator of future returns. The publishers of this report are not investment advisors and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. The publishers of this report have received compensation from a third party of USD $10,000 cash for a 1-day marketing contract for HMPQ . Never make investment decisions based on anything the publisher of this report says. This message is meant for informational and educational purposes only and does not provide investment advice.
